MedPath
TGA Approval

CIPLA AMBRISENTAN ambrisentan 5 mg tablet blister pack (282340)

282340

CIPLA AMBRISENTAN ambrisentan 5 mg tablet blister pack

Cipla Australia Pty Ltd

September 14, 2017

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/a762bc5685faa1f02073f762fd256d41.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/5a4780f1374ecbd3264a521e0c98e086.pdf

Active Ingredients

ambrisentan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.